Porton Pharma Solutions
SZSE · 300363
Market Cap$7.6B
Revenue$3.5B
Employees4359
Listed OnSZSE
Ticker300363
CEO / ExecMr. Nianfeng Ju
HeadquartersChongqing
MarketMainland China
Websitewww.portonpharma.com
Overview
Porton Pharma Solutions Ltd. provides contract development and manufacturing organization (CDMO) solutions for small molecules, tides, biologics, and conjugates from pre-clinical to commercial in China and internationally. It has a strategic collaboration with Aojin Life Sciences to advance XDC conjugate drugs; and strategic partnership with Dragon Sail Pharmaceutical to build a new ecosystem for ADC drug development, production, and supply chain. It also offers crystallization, bio catalysis, m
Data Note
This record combines exchange-directory fields with selected profile enrichment. Treat market data, leadership and financial figures as directional unless verified against company filings, exchange announcements or the issuer's own disclosures.